Literature DB >> 17337763

From B cell to plasma cell: regulation of V(D)J recombination and antibody secretion.

Lisa Borghesi1, Christine Milcarek.   

Abstract

B cell development culminates in the formation of plasma cells, potent secretors of the immunoglobulins (Ig), proteins crucial for the health of the organism. Two distinctive and crucial steps are required during B cell differentiation. First, variable gene segments encoding the antigen-binding region of Ig undergo directed rearrangement through a process known as V(D)J recombination. Second, alternative processing of the Ig heavy chain mRNA transcript enables plasma cells to secrete high levels of Ig protein. This review focuses on the molecular mechanisms that control V(D)J recombination in B cell progenitors and alternative RNA processing in plasma cells.

Mesh:

Substances:

Year:  2006        PMID: 17337763     DOI: 10.1385/IR:36:1:27

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  34 in total

1.  RAG2 is regulated differentially in B and T cells by elements 5' of the promoter.

Authors:  R J Monroe; F Chen; R Ferrini; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Capping, splicing, and 3' processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD.

Authors:  N Fong; D L Bentley
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

3.  The snRNP-associated U1A levels change following IL-6 stimulation of human B-cells.

Authors:  Christine Milcarek; Kathleen Martincic; Ling-Hsiu Chung-Ganster; Carol S Lutz
Journal:  Mol Immunol       Date:  2003-03       Impact factor: 4.407

4.  Regulation of herpes simplex virus poly (A) site usage and the action of immediate-early protein IE63 in the early-late switch.

Authors:  F McGregor; A Phelan; J Dunlop; J B Clements
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  The hnRNPs F and H2 bind to similar sequences to influence gene expression.

Authors:  Serkan A Alkan; Kathleen Martincic; Christine Milcarek
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

6.  Alternative poly(A) site utilization during adenovirus infection coincides with a decrease in the activity of a poly(A) site processing factor.

Authors:  K P Mann; E A Weiss; J R Nevins
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

7.  Characterization of chromatin structure and enhancer elements for murine recombination activating gene-2.

Authors:  Xing-Cheng Wei; Hiroyuki Kishi; Zhe-Xiong Jin; Wen-Pu Zhao; Sachiko Kondo; Tadashi Matsuda; Shigeru Saito; Atsushi Muraguchi
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

8.  Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer.

Authors:  P Cramer; J F Cáceres; D Cazalla; S Kadener; A F Muro; F E Baralle; A R Kornblihtt
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

9.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

10.  B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors.

Authors:  Lisa Borghesi; Lih-Yun Hsu; Juli P Miller; Michael Anderson; Leonard Herzenberg; Leonore Herzenberg; Mark S Schlissel; David Allman; Rachel M Gerstein
Journal:  J Exp Med       Date:  2004-02-09       Impact factor: 14.307

View more
  8 in total

Review 1.  B-cell receptor signaling as a driver of lymphoma development and evolution.

Authors:  Carsten U Niemann; Adrian Wiestner
Journal:  Semin Cancer Biol       Date:  2013-09-20       Impact factor: 15.707

2.  Increased gene targeting in Ku70 and Xrcc4 transiently deficient human somatic cells.

Authors:  Luciana R Bertolini; Marcelo Bertolini; Elizabeth A Maga; Knut R Madden; James D Murray
Journal:  Mol Biotechnol       Date:  2008-08-30       Impact factor: 2.695

3.  Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.

Authors:  Mallesh Beesu; Giuseppe Caruso; Alex C D Salyer; Karishma K Khetani; Diptesh Sil; Mihiri Weerasinghe; Hiromi Tanji; Umeharu Ohto; Toshiyuki Shimizu; Sunil A David
Journal:  J Med Chem       Date:  2015-09-22       Impact factor: 7.446

4.  Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.

Authors:  Yingji Jin; Seung Cheol Kim; Hyoung Jin Kim; Woong Ju; Yun Hwan Kim; Hong-Jin Kim
Journal:  Oncotarget       Date:  2017-11-01

5.  Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.

Authors:  Matthew J Bottomley; Mian Chen; Sue Fuggle; Paul N Harden; Kathryn J Wood
Journal:  Transplant Direct       Date:  2016-12-21

6.  [IGHV mutational statue in patients with splenic marginal zone lymphoma].

Authors:  W J Yang; Z Yu; R Lyu; Z J Li; H Li; W J Xiong; S H Yi; W Liu; L G Qiu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-09-14

Review 7.  The Evolution of Molecular Recognition: From Antibodies to Molecularly Imprinted Polymers (MIPs) as Artificial Counterpart.

Authors:  Ortensia Ilaria Parisi; Fabrizio Francomano; Marco Dattilo; Francesco Patitucci; Sabrina Prete; Fabio Amone; Francesco Puoci
Journal:  J Funct Biomater       Date:  2022-01-28

8.  Development of Immunocapture-LC/MS Assay for Simultaneous ADA Isotyping and Semiquantitation.

Authors:  Lin-Zhi Chen; David Roos; Elsy Philip
Journal:  J Immunol Res       Date:  2016-01-28       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.